Mylan Deals a Blow to Teva Pharmaceutical – Motley Fool

Mylan Deals a Blow to Teva Pharmaceutical
Motley Fool
Generic drugmakers Mylan (NASDAQ:MYL) and Teva Pharmaceutical (NYSE:TEVA) usually deal blows to brand-name drug manufacturers, not each other, but that changed last week when the Food and Drug Administration approved Mylan’s generic versionĀ …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd